LATS1 and ductal breast carcinoma in situ: The phenotype driven by Tamoxifen-induced Lats1/2 knockout in this system resembles basal-like ductal carcinoma in situ (DCIS) and is marked by rapid overgrowth of basal-like cells within mammary ducts (Kern et al, 2022).